go-v.orgdoi

p53/PCDH17/Beclin-1 Proteins as Prognostic Predictors for Urinary Bladder Cancer

Liuxi Chen, Ying Liu, Qi Zhang, Mingming Zhang, Xuemeng Han, Qiujie Li, Tian Xie, Qibiao Wu, Xinbing Sui · Journal of Cancer · 2019

  • DOI 10.7150/jca.37335
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2019

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2019

Abstract

Purpose: To determine whether p53, PCDH17, Beclin-1 expression is associated with clinicopathological characteristics of bladder cancer.Materials and Methods: 75 patients with non-muscle-invasive and muscle-invasive bladder cancer were included.Immunohistochemical staining for p53, PCDH17 and Beclin-1 were carried out on the same paraffin-embedded blocks serial sections of these patients who underwent surgery between 2010 and 2015.In addition, p53 gene mutations in these tumors were screened by DNA sequencing.Results: Forty-nine (66.7%) of 75 tumors had p53 gene mutations detected by DNA sequencing method.Of these tumors, 43 (86.0%)exhibited p53 high expression.Furthermore, p53 mutation and low expression of PCDH17 were significantly associated with muscle-invasive bladder cancer.Beclin-1 was also strongly associated with T stage.The p53 mutation, the expression of p53 and PCDH17 were significantly associated with survival from bladder cancer.In addition, patients with p53 high-expression or p53 mutation, PCDH17 low-expression and Beclin-1 low-expression significantly had a poor prognosis.Conclusions: Use of a DNA sequencing method to detect p53 gene mutations was consistent with an immunohistochemical method to detect p53 alterations.In conjunction with levels of p53/PCDH17/Beclin-1, p53 and PCDH17 were independently associated with prognosis; Beclin-1 only had a tendency towards overall survival.p53/PCDH17/Beclin-1 phenotype seems to play a more important role than p53 expression in bladder cancer outcome.It is also identified that p53/PCDH17, p53/Beclin-1 or PCDH17/Beclin-1 all have a cooperative and synergistic effect, which may provide us the potential biomarker for bladder cancer patients.

Open the resolved locator · 10.7150/jca.37335

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 21:17 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v10p6207.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.